Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches

0 Views
administrator
administrator
07/08/23

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches

Chair & Presenter, Bradley J. Monk, MD, FACS, FACOG, Kathleen N. Moore, MD, MS, and Jessica Thomes Pepin, MD, discuss ovarian cancer in this CME/MOC/NCPD activity titled โ€œWhen Are PARP Inhibitors the Best Choice for Patients With Ovarian Cancer? Personalizing Therapeutic Selection Across the Disease Continuum.โ€ For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD information, and to apply for credit, please visit us at PeerView.com/YWA865. CME/MOC/NCPD credit will be available until April 21, 2023.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next